{"id":37267,"date":"2025-09-09T22:38:29","date_gmt":"2025-09-09T22:38:29","guid":{"rendered":"https:\/\/usdailys.com\/?p=37267"},"modified":"2025-09-09T22:38:36","modified_gmt":"2025-09-09T22:38:36","slug":"center-for-reproductive-rights-sues-trump-administration-over-review-of-abortion-pill","status":"publish","type":"post","link":"https:\/\/usdailys.com\/?p=37267","title":{"rendered":"Center for Reproductive Rights Sues Trump Administration Over Review of Abortion Pill –"},"content":{"rendered":"

The Center for Reproductive Rights (CRR)<\/strong> filed a lawsuit against the Trump administration on Friday, seeking greater transparency regarding the federal government\u2019s decision to review the safety of the abortion pill mifepristone<\/strong>. The organization alleges that political interference may have influenced the FDA\u2019s actions.<\/p>\n

The complaint names the Department of Health and Human Services (HHS)<\/strong> and the Food and Drug Administration (FDA)<\/strong>, accusing the agencies of withholding information about the FDA\u2019s announcement to reevaluate mifepristone. CRR claims that both agencies failed to respond to prior requests made under the Freedom of Information Act (FOIA)<\/strong>, which requires federal bodies to provide requested records to the public.<\/p>\n

The lawsuit specifically seeks details about the FDA\u2019s review process for mifepristone, including the data used to justify reevaluating a drug that has been safely prescribed for over 25 years<\/strong>. CRR is also requesting information regarding any potential influence from HHS or outside parties on the agency\u2019s decision, highlighting concerns that political considerations may be shaping the process.<\/p>\n

\n

<\/p>\n

<\/div>\n<\/div>\n

In June<\/strong>, FDA Commissioner Martin Makary<\/strong> announced that the agency would review mifepristone. The announcement followed a controversial report published in April<\/strong>, which CRR and other experts have criticized as \u201cjunk science.\u201d That report claimed that nearly 11% of women<\/strong> experienced serious complications such as sepsis, infection, or hemorrhaging<\/strong> within 45 days of using mifepristone, a finding widely disputed by medical professionals.<\/p>\n

According to CRR, the close timing between the report\u2019s publication and the FDA\u2019s decision to review the drug \u201csuggests political interference.\u201d HHS and FDA did not immediately respond to requests for comment.<\/p>\n

\n

\u201cThe public deserves to know if the FDA is making decisions about medication abortion based on debunked information or in response to political pressure,\u201d said Rachana Desai Martin<\/strong>, CRR\u2019s chief U.S. program officer.<\/p>\n

\u201cThe Trump administration is targeting a drug that has been FDA-approved for 25 years and safely used by millions.\u201d<\/p>\n<\/blockquote>\n

The lawsuit marks the latest effort by reproductive rights groups to challenge government actions that could restrict access to medication abortion and underscores ongoing concerns about political influence over FDA decision-making.<\/p>\n

\"\"<\/p>\n

Ethics and Public Policy Center Report Sparks Controversy in FDA Review of Mifepristone<\/h2>\n

The Ethics and Public Policy Center (EPPC)<\/strong>, a conservative think tank and advisory board member of Project 2025<\/strong>, recently published a report that has played a central role in the federal review of the abortion pill mifepristone<\/strong>. Project 2025 is a right-wing policy agenda that advocates for the president\u2019s FDA appointees to ban the medication.<\/p>\n

Critics have described the EPPC report as junk science<\/strong>. The paper was not peer-reviewed<\/strong> and did not disclose its underlying data, making it impossible for other researchers to verify its findings. Data scientists told HuffPost that the report\u2019s conclusions do not align with the data it claims to analyze.<\/p>\n

A spokesperson for EPPC explained in April that the report was not submitted for peer review due to what the organization described as \u201cthe extensive pro-abortion bias in the peer-review process,\u201d which they claim prevents publication of analyses that critically examine mifepristone.<\/p>\n

The timing of the report\u2019s release raised eyebrows. It was published just days after FDA Commissioner Martin Makary<\/strong> stated he had no plans to restrict mifepristone unless new evidence showed the drug was unsafe. Soon after, anti-abortion advocates and lawmakers began using the report to argue that the pill should face restrictions.<\/p>\n

Sen. Josh Hawley (R-Mo.)<\/strong>, a prominent anti-abortion figure, sent a letter to Makary urging him to \u201cfollow this new data and take all appropriate action to restore critical safeguards on the use of mifepristone.\u201d Following Hawley\u2019s letter, which presented the EPPC report as factual, Makary announced the FDA would review the medication.<\/p>\n

HHS Secretary Robert F. Kennedy Jr.<\/strong> also told Hawley during a May Senate hearing that the EPPC report was \u201calarming\u201d and supported a review of mifepristone.<\/p>\n

\n

\u201cThe timing of the administration\u2019s interest in mifepristone and its reliance on discredited right-wing policy papers instead of long-standing peer-reviewed studies suggest that anti-abortion ideology is dictating the drug regulation process,\u201d said Rachana Desai Martin<\/strong>, chief U.S. program officer at the Center for Reproductive Rights.<\/p>\n<\/blockquote>\n

During a Senate hearing last week, Kennedy told lawmakers that he is working with Makary to review mifepristone and appeared to reference the EPPC report, citing the same 11% statistic<\/strong> used in the paper.<\/p>\n

\n

\u201cWe\u2019re getting data in all the time, new data that we\u2019re reviewing. And we know that during the Biden administration, they actually twisted the data to bury one of the safety signals, a very high safety signal \u2013 around 11%,\u201d Kennedy told Sen. James Lankford (R-Okla.)<\/strong>
\u201cSo we\u2019re gonna make sure that doesn\u2019t happen anymore.\u201d<\/p>\n<\/blockquote>\n

The report, its timing, and the subsequent FDA review have fueled concerns among reproductive rights advocates that political motivations, rather than scientific evidence, are influencing federal oversight of a medication safely used by millions for more than 25 years<\/strong>.<\/p>\n

 <\/p>\n

\n

<\/p>\n

<\/div>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

The Center for Reproductive Rights (CRR) filed a lawsuit against the Trump administration on Friday, seeking greater transparency regarding the federal government\u2019s decision to review the safety of the abortion … <\/p>\n","protected":false},"author":2,"featured_media":37268,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-37267","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts\/37267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37267"}],"version-history":[{"count":2,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts\/37267\/revisions"}],"predecessor-version":[{"id":37270,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/posts\/37267\/revisions\/37270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=\/wp\/v2\/media\/37268"}],"wp:attachment":[{"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/usdailys.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}